Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen in the cervix forms a key component of the extracellular matrix, determining the tissue’s structure, compliance, and ability to remodel. During pregnancy, the cervix undergoes dynamic remodeling with a characteristic decline in cross-linked collagen, increased collagen turnover, and alteration in matrix organization to allow cervical softening, ripening, and eventual dilation. After injury, surgery, or intervention (such as laser therapy or scaffold implantation), collagen regeneration facilitates restoration of cervical anatomy and function. This process is influenced by inflammatory mediators, hormones (progesterone, estrogen), paracrine signaling, and the presence of immune cells like macrophages, and is a focus of regenerative medicine approaches using scaffolds or stem cells.
Not applicable in the classic pharmacological sense, but targeted therapies might act by modulating inflammation, enhancing extracellular matrix deposition, or regulating metalloproteinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen in cervical extracellular matrix.